Related references
Note: Only part of the references are listed.A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms
Giovanni Clemente Actis et al.
REVIEWS ON RECENT CLINICAL TRIALS (2019)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2017)
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy ininflammatory bowel disease
W. Moon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Clinical practice guideline: management of acute pancreatitis
Joshua A. Greenberg et al.
CANADIAN JOURNAL OF SURGERY (2016)
Genes implicated in thiopurine-induced toxicity: Comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort
Tracy Coelho et al.
SCIENTIFIC REPORTS (2016)
Drug-Induced Liver Injury
Leslie A. Hamilton et al.
AACN ADVANCED CRITICAL CARE (2016)
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
Marieke J. H. Coenen et al.
GASTROENTEROLOGY (2015)
Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis
Yue-Ping Liu et al.
PLOS ONE (2015)
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells
Amedeo De Nicolo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease
L. Chouchana et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
AM Marinaki et al.
PHARMACOGENETICS (2004)
Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway
T Loennechen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)
Share Paper
